The anesthetic urethane blocks excitatory amino acid responses but not GABA responses in isolated frog spinal cords

Journal of Anesthesia

Volumn 27, Issue 1, 2013, Pages 98-103

  Daló, Nelson L ^a,b   Hackman, John C ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

Author keywords

EAA; GABA; Spinal cord; Urethane

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; EXCITATORY AMINO ACID; EXCITATORY AMINO ACID RECEPTOR; GLUTAMIC ACID; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; POTASSIUM ION; URETHAN;

ANESTHESIA INDUCTION; ANESTHESIA MECHANISM; ANIMAL TISSUE; ANURA; ARTICLE; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DORSAL ROOT; DRUG SELECTIVITY; MOTONEURON; MUSCLE SPINDLE AFFERENT NERVE; NERVE POTENTIAL; NONHUMAN; PRIMARY AFFERENT DEPOLARIZATION; SPINAL CORD; STIMULUS RESPONSE; VENTRAL ROOT;

ANESTHETICS, INTRAVENOUS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS; EXCITATORY AMINO ACID ANTAGONISTS; GABA ANTAGONISTS; MOTOR NEURONS; POTASSIUM; RANA PIPIENS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD; SPINAL CORD INJURIES; SPINAL NERVE ROOTS; URETHANE;

EID: 84874116809     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-012-1466-7     Document Type: Article

References (27)

1. Fragoza K, Alston TA. Liquor made quicker: alcohol as a synthetic reagent for molecules in anesthesia. J Clin Anesth. 2008;20:556-9.
2. Maggi CA, Meli A. Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Experientia. 1986;42:109-210.
3. Koblin DD. Urethane: help or hindrance? Anesth Analg. 2002;94:241-2.
4. Clement EA, Richard A, Thwaites M, Ailon J, Peters S, Dickson CT. Cyclic and sleep-like spontaneous alteration of brain state under urethane anesthesia. PLoS ONE. 2008;3(4):e2004.
5. Sonner JM, Antognini JF, Dutton RC, Flood P, Gray AT, Harris RA, Homanics GE, Kendig J, Orser B, Raines DE, Trudell J, Vissel B, Eger EI II. Inhaled anesthetics and immobility: mechanisms, mysteries, and minimum alveolar anesthetic concentration. Anesth Analg. 2003;97:718-40.
6. Evans RH, Smith DAS. Effect of urethane on synaptic and amino acid-induced excitation in isolated spinal cord preparations. Neuropharmacology. 1982;21:857-60.
7. Shirasaka Y, Wasterlain CG. The effect of urethane anesthesia on evoked potentials in dentate gyrus. Eur J Pharmacol. 1995;282:11-7.
8. Hara K, Harris RA. The anesthetic mechanism of urethane: the effect on neurotransmitter-gated ion channels. Anesth Analg. 2002;94:313-8.
9. Daló NL, Larson AA. Effects of urethane and ketamine on substance P- and excitatory amino acid-induced behavior in mice. Eur J Pharmacol. 1990;184:173-7.
10. Accorsi-Mendonca D, Leao RM, Aguilar JF, Varanda WA, Machado BH. Urethane inhibits the GABAergic neurotransmission in the nucleus of the solitary tract of rat brain stem slices. Am J Physiol Regul Integr Comp Physiol. 2007;292:R396-402.
11. Antkowiak B. How do general anaesthetics work? Naturwissenschaften. 2001;88:201-13.
12. Franks NP. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev. 2008;9:370-86.
13. A or glycine receptors. J Pharmacol Exp Ther. 1999;290:362-7.
14. Garrett KM, Gan J. Enhancement of γ-aminobutyric acid receptor activity by alpha-chloralose. J Pharmacol Exp Ther. 1998;285:680-6.
15. Evans RH, Smith DAS, Watkins JC. Amino acid antagonist property of urethane. Br J Pharmacol. 1981;74:908P.
16. Davidoff RA, Hackman JC. Hyperpolarization of frog primary afferent fibers caused by activation of a sodium pump. J Physiol (Lond.). 1980;302:297-309.
17. Kudo Y. The pharmacology of the amphibian spinal cord. Prog Neurobiol. 1978;11:1-76.
18. Magherini PC, Precht W. Electrical properties of frog motoneurons in the in situ spinal cord. J Neurophysiol. 1976;39:459-73.
19. Evans RH, Francis AA, Hon K, Oakes DJ, Watkins JC. Antagonism of excitatory amino acid-induced responses and synaptic activity in isolated spinal cord of the frog in situ. Br J Pharmacol. 1979;67:591-603.
20. Hackman JC, Davidoff RA. Dorsal root potentials in the isolated frog spinal cord: amino acid neurotransmitters and magnesium ions. Neurosciences. 1991;41:61-9.
21. Long SK, Evans RH, Cull L, Krijzer F, Bevan P. An in vitro mature spinal cord preparation from the rat. Neuropharmacology. 1988;27:541-6.
22. + channels. J Pharmacol Exp Ther. 2004;309:987-94.
23. Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orsen BA, Harrison NL. Emerging molecular mechanisms of general anesthetic action. Trend Pharmacol Sci. 2005;26:503-10.
24. Obata SM, Goto SS. Antinociception with intrathecal alpha-methyl-5- hydroxytryptamine, a 5-hydroxytryptamine 2A/2C receptor agonist, in two models of sustained pain. Anesth Analg. 2003;96:1072-8.
25. Holohean AM, Hackman JC, Davidoff RA. Changes in membrane potential of frog motoneurons induced by activation of serotonin receptor subtypes. Neurosciences. 1990;34:555-64.
26. Dringenberg HC, Vanderwolf CH, Hamilton JT. Urethane reduces contraction to 5-hydroxytryptamine (5-HT) and enhances the action of the 5-HT antagonist ketaserin on the rat thoracic aortic ring. J Neural Transm. 1995;101:183-93.
27. Davidoff RA, Hackman JC, Holohean AM, Vega JL, Zhang DX. Primary afferent fiber activity, putative excitatory transmitters and extracellular potassium in the frog spinal cord. J Physiol (Lond.). 1988;397:291-306.